SCHEMBL14916922

SCHEMBL14916922

CNC(=O)c1cn(C)c2ccc(C(=O)c3c(C)c(-c4ccncc4)c4ccccn34)cc2c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 4/20 0.42
▸ S1PR3 Q99500 4/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ NR4A2 P43354 2/20 0.41
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ MAPT P10636 4/20 0.39
▸ MAOB P27338 3/20 0.38
▸ POLB P06746 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14916431 0.99 S1PR1 (0.42) S1PR1S1PR3MEN1ALDH1A1CYP1A2
SCHEMBL321215 0.84 NR4A2 (0.43) MEN1ALDH1A1HTTKMT2ANR4A2
SCHEMBL320796 0.79 MAPT (0.50) MEN1ALDH1A1CYP1A2GAACYP2D6
SCHEMBL17004161 0.75 ALDH1A1 (0.41) MEN1ALDH1A1CYP1A2CYP3A4GAA
SCHEMBL320775 0.73 POLB (0.41) ALDH1A1HTTKMT2ANR4A2RAB9A
SCHEMBL321051 0.70 ALDH1A1 (0.44) MEN1ALDH1A1GAAKMT2ANR4A2
SCHEMBL10085592 0.69 NR4A2 (0.56) MEN1ALDH1A1GAAKMT2ANR4A2
SCHEMBL10341234 0.69 KDM4E (0.72) S1PR1S1PR3ALDH1A1HTTKMT2A
SCHEMBL12505747 0.68 POLB (0.42) MEN1ALDH1A1KMT2AKDM4EL3MBTL1
SCHEMBL321695 0.68 MAPT (0.53) MEN1ALDH1A1CYP1A2GAACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590975-B1 INDOLIZINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2015-08-19 — — EP disclosed
US-8859544-B2 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof SANOFI (FR) 2014-10-14 — — US disclosed
US-20130116249-A1 INDOLIZINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116249-A1 INDOLIZINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THERAPEUTIC USE THEREOF CCNY, INMT, IDO1 S1PR1 2202/4885S1PR3 1548/4885MEN1 1964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback